JPS56135419A - Preventive and improver for radiation disorder - Google Patents

Preventive and improver for radiation disorder

Info

Publication number
JPS56135419A
JPS56135419A JP3823580A JP3823580A JPS56135419A JP S56135419 A JPS56135419 A JP S56135419A JP 3823580 A JP3823580 A JP 3823580A JP 3823580 A JP3823580 A JP 3823580A JP S56135419 A JPS56135419 A JP S56135419A
Authority
JP
Japan
Prior art keywords
bacterium
oligosaccharides
improver
preventive
gal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3823580A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6241569B2 (enrdf_load_html_response
Inventor
Masahiko Mutai
Teruo Yokokura
Masaharu Onoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP3823580A priority Critical patent/JPS56135419A/ja
Publication of JPS56135419A publication Critical patent/JPS56135419A/ja
Publication of JPS6241569B2 publication Critical patent/JPS6241569B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP3823580A 1980-03-27 1980-03-27 Preventive and improver for radiation disorder Granted JPS56135419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3823580A JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3823580A JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Publications (2)

Publication Number Publication Date
JPS56135419A true JPS56135419A (en) 1981-10-22
JPS6241569B2 JPS6241569B2 (enrdf_load_html_response) 1987-09-03

Family

ID=12519630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3823580A Granted JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Country Status (1)

Country Link
JP (1) JPS56135419A (enrdf_load_html_response)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330054A1 (en) * 2007-10-11 2010-12-30 Fayrefield Foods Limited Preparation, use of preparation for treatment, and method of treatment of intestinal infection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330054A1 (en) * 2007-10-11 2010-12-30 Fayrefield Foods Limited Preparation, use of preparation for treatment, and method of treatment of intestinal infection

Also Published As

Publication number Publication date
JPS6241569B2 (enrdf_load_html_response) 1987-09-03

Similar Documents

Publication Publication Date Title
Kohwi et al. Antitumor effect of Bifidobacterium infantis in mice
Riggio et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients
Terada et al. Effect of lactulose on the composition and metabolic activity of the human faecal flora
CA2099855C (en) Antigastritis agent
Sanders Lactic acid bacteria as promoters of human health
Guarner Inulin and oligofructose: impact on intestinal diseases and disorders
Bolognani et al. Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens
Cunningham-Rundles et al. Probiotics and immune response
Kolida et al. Prebiotic effects of inulin and oligofructose
Taper et al. Possible adjuvant cancer therapy by two prebiotics-inulin or oligofructose
EP1112692B1 (en) Drinks and foods capable of eliminating helicobacter pylori
Voorhess et al. URINARY EXCRETION OF NOREPINEPHRINE, EPINEPHRINE AND 3-METHOXY-4-HYDROXYMANDELIC ACID BY CHILDREN WITH NEURO-BLASTOMA
Parodi The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics
Cole et al. Effect of Probiotic Supplements of Lactobacillus acidophilus and Bifidobacterium adolescentis 2204 on β-glueosidase and β-glueuronidase Activity in the Lower Gut of Rats Associated with a Human Faecal Flora
BRPI0206689B1 (pt) composição de probióticos e uso desta
PT1649760E (pt) Composição contendo uma bactéria de ácido láctico produzindo equol
US5895758A (en) Strain of lactobacillus Plantarum
JP4712289B2 (ja) 免疫促進用組成物
Adachi Lactic acid bacteria and the control of tumours
WO1999017788A1 (en) Composition of treatment of candidiasis
JPS56135419A (en) Preventive and improver for radiation disorder
KR20220008218A (ko) 염증성 장질환 예방 또는 치료용 조성물
WO2002045727A1 (en) Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
Vanderhoof et al. The role of probiotics in the treatment of intestinal infections and inflammation
Rice et al. The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis